NBE Therapeutics
NBE Therapeutics is a Basel-based biotechnology company specializing in oncology. The company has developed an antibody drug conjugate platform targeting solid tumors.
2
Funding Rounds
$42.0m
Money raised
Overview
NBE Therapeutics is a Basel-based biotechnology company specializing in oncology. The company has developed an antibody drug conjugate platform targeting solid tumors.
- Website:
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company NBE Therapeutics has raised a total of $20m in funding over 2 rounds.
Key Insights:
- NBE-Therapeutiecs Series B round, June 2018: $20m
- NBE Therapeutics Series C round January 2020: $22m
NBE-Therapeutiecs Series B round, June 2018
$20m
NBE Therapeutics Series C round January 2020
$22m
Industries
NBE Therapeutics is active in the following industries: